Recent News

• 01.21.2026 - DE LA SOUL-LED “GOOD HEALTH SUMMIT” LAUNCHES FEBRUARY 19 AT MOREHOUSE COLLEGE
• 01.20.2026 - LIXTE Biotechnology Attending the DealFlow Discovery Conference, January 28-29
• 12.23.2025 - LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial
• 12.18.2025 - Lixte Biotechnology Holdings, Inc. Announces $4.3 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
• 11.25.2025 - LIXTE Biotechnology Acquires Liora Technologies’ Proprietary Proton Therapy Platform for Cancer Treatment
• 10.29.2025 - LIXTE Biotechnology Holdings to Present at the Spartan Capital Investor Conference 2025, November 3

Recent Filings

• 12.31.2025 - 8-K Current report
• 12.29.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.29.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.23.2025 - 8-K Current report
• 12.23.2025 - EX-99.1 EX-99.1
• 12.22.2025 - EX-99.1 EX-99.1
• 12.22.2025 - 8-K Current report
• 12.19.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 12.11.2025 - 8-K Current report
• 11.28.2025 - 25-NSE/A Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities